血清铁在2型糖尿病患者骨质疏松中的研究进展
Research Progress of Serum Iron in Osteoporosis of Type 2 Diabetes Patients
摘要: 铁是人体中众多微量元素之一,其参与体内多种氧化反应催化生成多种氧自由基,是许多酶的重要组成部分,机体铁含量缺乏时,将会损害糖的分解,导致血糖的升高,此外,铁含量的下降将会使自由基产生过多,氧化应激反应增强,从而促进了糖尿病的发生发展,2型糖尿病和骨质疏松都是比较高发的慢性代谢性疾病,也是患病率、致残率及致死率较多的疾病之一,极大地降低了患者的生活质量,威胁患者的生命健康,同时也给社会带来了极大的负担以及经济压力,但是目前其发病机制仍不明确,为此,本文总结相关文献内容,并介绍血清铁在2型糖尿病患者骨质疏松中的研究进展,为今后的研究提供参考。
Abstract: Iron is one of the many trace elements in the human body. It participates in various oxidation reac-tions in the body and catalyzes the generation of a variety of oxygen free radicals. It is an important part of many enzymes. When the body is deficient in iron, it will damage the decomposition of sugar, leading to the increase of blood sugar. In addition, the decrease of iron content will lead to the gen-eration of excessive free radicals and the enhancement of oxidative stress reaction, thus promoting the occurrence and development of diabetes, Type 2 diabetes and osteoporosis are both chronic metabolic diseases with high incidence, and are also one of the diseases with high prevalence, disa-bility and mortality rates. They greatly reduce the quality of life of patients, threaten their life and health, and also bring great burden and economic pressure to the society. However, the pathogene-sis is still unclear. Therefore, this paper summarizes the relevant literature. The research progress of serum iron in type 2 diabetes patients with osteoporosis was also introduced, providing reference for future research.
文章引用:高玲艳, 韩吉祥. 血清铁在2型糖尿病患者骨质疏松中的研究进展[J]. 临床医学进展, 2023, 13(1): 474-477. https://doi.org/10.12677/ACM.2023.131070

参考文献

[1] Kanis, J.A., Cooper, C., Rizzoli, R., et al. (2019) European Guidance for the Diagnosis and Management of Osteoporosis in Postmenopausal Women. Osteoporosis International, 30, 30-44. [Google Scholar] [CrossRef] [PubMed]
[2] (1993) Consensus Development Conference: Diagnosis, Prophy-laxis, and Treatment of Osteoporosis. The American Journal of Medicine, 94, 646-650. [Google Scholar] [CrossRef
[3] Albright, F. and Reifenstein, E.C. (1948) The Parathyroid Glands and Metabolic Bone Disease: Selected Studies. Williams & Wilkins Co., Philadelphia, 188.
[4] Schacter, G.I. and Leslie, W.D. (2017) Diabetes and Bone Disease. Endocrinology & Metabolism Clinics of North America, 46, 63-85. [Google Scholar] [CrossRef] [PubMed]
[5] Mohsin, S., Baniyas, M.M., Aldarmaki, R.S., et al. (2019) An Up-date on Therapies for the Treatment of Diabetes-Induced Osteoporosis. Expert Opinion on Biological Therapy, 19, 937-948. [Google Scholar] [CrossRef] [PubMed]
[6] Piriyakhuntorn, P., Tantiworawit, A., Phimphilai, M., et al. (2020) Impact of Iron Overload on Bone Remodeling in Thalassemia. Archives of Osteoporosis, 15, 143. [Google Scholar] [CrossRef] [PubMed]
[7] 田青, 刘勇, 李国庆, 杨述华, 杜靖远, 邵增务. 老年骨质疏松骨折血清铁水平的测定及临床意义[J]. 临床急诊杂志, 2013, 14(3): 111-112+116. [Google Scholar] [CrossRef
[8] Zhao, G.Y., Zhao, L.P., He, Y.F., et al. (2012) A Comparison of the Biological Activities of Human Osteoblast hFOB1.19 between Iron Excess and Iron Deficiency. Bio-logical Trace Element Research, 150, 487-495. [Google Scholar] [CrossRef] [PubMed]
[9] 姜宇, 徐又佳. 铁调素与骨质疏松鼠[J]. 中国骨质疏松杂志, 2017, 23(2): 256-258.
[10] Li, X., Ye, Z., Guo, Q., et al. (2021) PDTC Ameliorates Neuropathic Pain by Inhibiting Mi-croglial Activation via Blockage of the TNFα-CX3CR1 Pathway. European Journal of Histochemistry, 65, 3184. [Google Scholar] [CrossRef] [PubMed]
[11] Li, G., Zhang, H., Wu, J., et al. (2020) Hepcidin Deficiency Causes Bone Loss through Interfering with the Canonical Wnt/β-Catenin Pathway via Forkhead Box O3a. The Journal of Or-thopaedic Translation, 23, 67-76. [Google Scholar] [CrossRef] [PubMed]
[12] Yuan, Y., Xu, F., Cao, Y., et al. (2019) Iron Accumulation Leads to Bone Loss by Inducing Mesenchymal Stem Cell Apoptosis through the Activation of Caspase 3. Biological Trace Ele-ment Research, 187, 434-441. [Google Scholar] [CrossRef] [PubMed]
[13] Braymer, J.J. and Lill, R. (2017) Iron-Sulfur Cluster Biogenesis and Trafficking in Mitochondria. Journal of Biological Chemistry, 292, 12754-12763. [Google Scholar] [CrossRef
[14] Kiyo-aki, I., Toshio, F., Kazuhiro, I., et al. (2009) Coordination of PGC-1beta and Iron Uptake in Mitochondrial Biogenesis and Osteoclast Activation. Nature Medicine, 15, 259-266. [Google Scholar] [CrossRef] [PubMed]
[15] Yang, J., Dong, D., Luo, X., et al. (2020) Iron Overload-Induced Osteocyte Apoptosis Stimulates Osteoclast Differentiation through Increasing Osteocyticrankl Production in Vitro. Calcified Tissue International, 107, 499-509. [Google Scholar] [CrossRef] [PubMed]
[16] 王啸, 孙婧悦, 华俊, 徐又佳. 铁通过NF-κB通路调控小鼠破骨样细胞分化机制[J]. 中华骨质疏松和骨矿盐疾病杂志, 2022, 15(3): 257-263.
[17] 王啸. “铁蓄积”影响骨代谢的临床观察及分子机制[D]: [博士学位论文]. 苏州: 苏州大学, 2018.
[18] 申力, 邢丽莉, 李鸿江, 等. 骨代谢标志物变化情况与绝经后女性发生骨质疏松性椎体压缩骨折的相关性分析[J]. 颈腰痛杂志, 2019, 40(3): 305-307.
[19] 王庆玲, 岳伟, 张欣欣, 等. 铁代谢异常与非酒精性脂肪性肝病的关系[J]. 中华健康管理学杂志, 2020, 14(6): 587-591.
[20] 张玥, 张慧娟. 铁代谢与糖尿病及其并发症的关系[J]. 国际内分泌代谢杂志, 2020, 40(2): 117-120.
[21] Yuan, Y., Fang, Y., Zhu, L., et al. (2020) Deterioration of Hematopoietic Autophagy Is Linked to Osteoporosis. Aging Cell, 19, e13114. [Google Scholar] [CrossRef] [PubMed]
[22] Chen, B., Li, G.F., Shen, Y., et al. (2015) Reducing Iron Accumulation: A Potential Approach for the Prevention and Treatment of Postmenopausal Osteo-porosis. Experimental and Therapeutic Medicine, 10, 7-11. [Google Scholar] [CrossRef] [PubMed]
[23] Kim, B.J., Ahn, S.H., Bae, S.J., et al. (2012) Iron over Load Acceler-ates Bone Loess in Healthy Postmenopausal Women and Middle-Aged Men: A 3-Year Retrospective Longitudinal Study. Journal of Bone and Mineral Research, 27, 2279-2290. [Google Scholar] [CrossRef] [PubMed]
[24] 李小玲, 张玫, 于霆, 等. 血清铁与糖尿病性骨质疏松的关系研究[J]. 临床和实验医学杂志, 2015, 14(5): 357-359.
[25] 陈夏明, 姚敏. 2糖尿病患者铁代谢指标的变化及其意义[J]. 山东医药, 2014, 54(41): 34-35.